Recombinant Human Serpin A4/Kallistatin Protein, CF Summary
Details of Functionality
Measured by its ability to inhibit KLK1 cleavage of a fluorogenic peptide substrate, Pro-Phe-Arg-7-amido-4-methylcoumarin (PFR-AMC). The IC50 value is <40 nM, as measured under the described conditions.
Source
Mouse myeloma cell line, NS0-derived human Serpin A4/Kallistatin protein Gln21-Pro427, with a C-terminal 10-His tag
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Inhibition Activity
Theoretical MW
48 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
57 kDa and 61 kDa, reducing conditions
Publications
Read Publications using 1669-PI in the following applications:
1,10-Phenanthroline (Sigma, Catalog # 320056), 0.6 M stock in DMSO
Substrate: Pro-Phe-Arg-7-amido-4-methylcoumarin (Bachem, Catalog # I-1295), 10 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
Activate rhKLK1 at 100 µg/mL with 1 µg/mL Thermolysin in Activation Buffer.
Incubate at 37 °C for 1 hour.
Add 1,10-Phenathroline at a final concentration of 10 mM to stop activation reaction.
Prepare a curve of rhSerpin A4 (47710 Da) in Inhibition Buffer. Make the following serial dilutions: 8000, 4000, 2000, 1000, 625, 415, 200, and 75 nM.
Dilute activated rhKLK1 to 5 µg/mL in Inhibition Buffer.
Combine 20 µL of 5 µg/mL rhKLK1 with 20 µL of rhSerpin A4 curve dilutions. Include two controls of 20 µL Inhibition Buffer with 20 µL of 5 µg/mL rhKLK1.
Incubate curve at 37 °C for 1 hour.
Dilute curve 12.5 fold by adding 460 µL of Assay Buffer to each dilution.
Dilute Substrate to 200 µM in Assay Buffer.
In a plate load 50 µL of the rhSerpin A4 curve, and start the reaction by adding 50 µL of 200 µM Substrate to wells.
Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
Derive the 50% inhibiting concentration (IC50) of rhSerpin A4 by plotting RFU/min (or specific activity) vs. concentration with 4-PL fitting.
The specific activity for rhKLK1 at each point may be determined using the following formula (if needed):
Specific Activity (pmol/min/µg) =
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)
*Adjusted for Substrate Blank **Derived using calibration standard 7-amino, 4-Methyl Coumarin (Sigma, Catalog # A-9891).
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human Serpin A4/Kallistatin Protein, CF
antitrypsin), member 4
KAL
Kallistatin
KLST
KSTKallikrein inhibitor
member 4
PI-4
PI4Peptidase inhibitor 4
protease inhibitor 4 (kallistatin)
serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase
Serpin A4
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin)
Background
Serpin A4 is a member of the Serpin superfamily of the serine protease inhibitors (1). Known also as kallistatin or proteinase inhibitor 4, Serpin A4 has been shown to function as a specific inhibitor of tissue kallikrein and as an inhibitor of angiogenesis and tumor growth (2, 3).
Silverman, G.A. et al. (2001) J. Biol. Chem. 276:33293.
Chen, V.C. et al. (2000) J. Biol. Chem. 275:40371.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human Serpin A4/Kallistatin Protein, CF and receive a gift card or discount.